The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
ATP6V1G2 encodes the V-type proton ATPase subunit G2, also known as V-ATPase 13 kDa subunit 2 or vacuolar proton pump subunit G2 (UniProt: O95670) (abbas2020structureofvatpase pages 1-2). The protein belongs to the V-ATPase G subunit family and contains the V-ATPase_G domain (IPR005124; PF03179). Mammals possess three genes encoding G subunit isoforms: ATP6V1G1 (ubiquitous G1), ATP6V1G2 (brain-enriched G2), and ATP6V1G3 (kidney-enriched G3), reflecting tissue-specific functional specialization within the V-ATPase system (eaton2021theh+atpase(vatpase) pages 1-5, kawamura2015lossofg2 pages 1-2).
V-ATPases are large multiprotein complexes consisting of approximately 830,000 Da that function as ATP-driven rotary proton pumps (eaton2021theh+atpase(vatpase) pages 1-5). The enzyme comprises two major domains: the cytosolic V1 sector responsible for ATP hydrolysis and the membrane-embedded V0 sector that mediates proton translocation (wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2).
The V1 domain contains eight different subunits with the stoichiometry A3B3CDE3FG3H (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3). The V0 domain comprises subunits a, c8-14, c', c'', d, e, and in mammals also includes ATP6AP1/Ac45 and ATP6AP2/PRR (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3). Recent cryo-electron microscopy structures of mammalian V-ATPase from rat and bovine brain at 3.4-3.9 Å resolution, as well as human V-ATPase structures at 2.9-3.4 Å resolution, have provided detailed atomic models defining the enzyme's ATP:proton ratio as 3:10 (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3).
ATP6V1G2 encodes a small ~13 kDa protein of 118 amino acids (in mouse) that functions as part of the peripheral stalk architecture in the V1 domain (kawamura2015lossofg2 pages 1-2). The G subunit does not directly participate in catalysis or proton translocation; rather, it plays a critical structural role in coupling these two activities.
The G subunit interacts with the E subunit to form an elongated, rod-like heterodimeric structure (vasanthakumar2019structuralcomparisonof pages 1-2, kawamura2015lossofg2 pages 1-2). Three such EG heterodimers constitute the peripheral stalks that connect the catalytic A3B3 head of V1 to the membrane-embedded V0 sector (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, vasanthakumar2019structuralcomparisonof pages 1-2). These peripheral stalks interact with subunits C, H, and the N-terminal domain of the a subunit, forming a critical stator structure (abbas2020structureofvatpase pages 1-2, vasanthakumar2019structuralcomparisonof pages 1-2).
The peripheral stalks serve as stators that prevent unproductive co-rotation of the catalytic A3B3 hexamer during the enzyme's rotary mechanism (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2). During operation, ATP hydrolysis at the A/B subunit interfaces drives rotation of the central stalk (subunits D, F) and the c-ring in V0, while the peripheral stalks hold the A3B3 head stationary (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3). This mechanical coupling is essential for converting the energy of ATP hydrolysis into proton translocation across the membrane.
Studies suggest that the peripheral stalks may act like elastic springs, evening out different energy contributions across the three unequal steps of the rotation cycle (vasanthakumar2019structuralcomparisonof pages 1-2). The altered affinities of G and E subunits with C, H, and a subunits contribute to regulation of V-ATPase assembly and activity (futai2019vacuolartypeatpasea pages 1-3, vasanthakumar2019structuralcomparisonof pages 1-2).
V-ATPase operates as an ATP-driven proton pump, with the catalytic sites located at the interfaces between A and B subunits in the A3B3 hexamer (futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2). The enzyme hydrolyzes ATP to ADP and inorganic phosphate, using the released energy to drive conformational changes that rotate the central stalk and c-ring (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3).
Proton transport occurs through a sophisticated pathway involving the c-ring and subunit a (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3). Conserved glutamate residues on each c subunit become sequentially protonated as rotation drags them through the hydrophobic membrane environment (vasanthakumar2019structuralcomparisonof pages 3-4). The protonated glutamates are then positioned at the luminal half-channel in subunit a, where formation of a salt bridge with an essential arginine (R735 in yeast Vph1p, R795 in Stv1p) causes deprotonation and release of protons into the organelle lumen or extracellular space (vasanthakumar2019structuralcomparisonof pages 3-4).
The functional substrates for the holoenzyme are ATP (as the energy source) and protons (as the transported species) (wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3). ATP6V1G2 itself does not possess independent catalytic activity or alter substrate specificity; its role is to maintain the structural integrity and mechanical coupling of the complex during the catalytic cycle.
ATP6V1G2 exhibits brain-specific and neuron-enriched expression patterns, distinguishing it from the ubiquitously expressed G1 isoform (merkulova2015mappingtheh+ pages 1-2, kawamura2015lossofg2 pages 1-2). Within the brain, neurons express the unique G2 isoform in addition to G1, whereas non-neuronal cells such as astrocytes and glia express only the G1 isoform (kawamura2015lossofg2 pages 1-2). The kidney-enriched G3 isoform represents the third mammalian G subunit variant (kawamura2015lossofg2 pages 1-2).
Mass spectrometry analysis of V-ATPase purified from rat brain synaptic vesicles identified G2 as the predominant G subunit (with approximately 83% G2 and 17% G1), confirming its enrichment in neuronal vesicular compartments (abbas2020structureofvatpase pages 1-2).
V-ATPases containing ATP6V1G2 are predominantly localized to intracellular acidic organelles in neurons, including:
Unlike specialized V-ATPases in osteoclasts, kidney intercalated cells, or sperm that localize to the plasma membrane for extracellular acidification, G2-containing V-ATPases appear to function primarily in intracellular compartments (eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, kawamura2015lossofg2 pages 1-2).
A primary function of ATP6V1G2-containing V-ATPases in neurons is the acidification of synaptic vesicles (abbas2020structureofvatpase pages 1-2, kawamura2015lossofg2 pages 1-2). The proton gradient established by V-ATPase provides the chemiosmotic energy required for vesicular neurotransmitter transporters to load neurotransmitters (such as glutamate, GABA, acetylcholine) into synaptic vesicles against their concentration gradients (abbas2020structureofvatpase pages 1-2, kawamura2015lossofg2 pages 1-2). This function is essential for synaptic transmission and neuronal communication.
V-ATPase-mediated acidification is fundamental to the endolysosomal system (eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3). Functions include:
Beyond its proton-pumping activity, V-ATPase serves as a signaling platform and interaction hub (wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5, chen2024vatpaseincancer pages 1-3). Key signaling roles include:
V-ATPase subunits interact with small GTPases and trafficking machinery to regulate vesicle formation, targeting, and fusion events (futai2019vacuolartypeatpasea pages 1-3, merkulova2015mappingtheh+ pages 1-2). The enzyme has been implicated in coat formation, SNARE-dependent fusion processes, and organelle biogenesis along both the endocytic and exocytic pathways (eaton2021theh+atpase(vatpase) pages 1-5, merkulova2015mappingtheh+ pages 1-2).
The G2 subunit forms a stable heterodimer with the E subunit, constituting the peripheral stalk of V-ATPase (vasanthakumar2019structuralcomparisonof pages 1-2, kawamura2015lossofg2 pages 1-2). These EG heterodimers interact functionally with:
Alterations in G/E subunit composition affect the affinities for C, H, and a subunits, potentially regulating V-ATPase assembly and function (futai2019vacuolartypeatpasea pages 1-3, vasanthakumar2019structuralcomparisonof pages 1-2).
The peripheral stalks play important roles in the reversible assembly and disassembly of V1 and V0 domains, a major regulatory mechanism for V-ATPase activity (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2). Upon glucose starvation in yeast, V-ATPase can dissociate into separate V1 and V0 subcomplexes that are both autoinhibited; reassociation restores activity (eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2). The structural framework provided by the EG peripheral stalks is essential for coordinating this reversible assembly process.
A kidney V-ATPase interactome study identified numerous assembly factors, chaperones (including the CCT/TRiC complex), and trafficking proteins that associate with V-ATPase, highlighting the complexity of quality control and regulatory mechanisms (merkulova2015mappingtheh+ pages 1-2). While this study did not detect ATP6V1G2 (consistent with its brain-specific expression), the principles of regulated assembly likely generalize across V-ATPase populations.
Gene targeting studies in mice have provided direct evidence for ATP6V1G2 function and compensation (kawamura2015lossofg2 pages 1-2). Mice lacking functional G2 (G2-null mice) showed no apparent disorders in brain architecture or behavior, indicating that G2 is not strictly essential for viability or gross neuronal function (kawamura2015lossofg2 pages 1-2).
In G2-null mouse brains, the ubiquitous G1 isoform accumulated at higher protein levels than in wild-type animals, without a corresponding increase in G1 mRNA (kawamura2015lossofg2 pages 1-2). This post-transcriptional compensation suggests that loss of G2 is buffered by increased stability or assembly of G1-containing V-ATPase complexes. The ability of G1 to substitute for G2 indicates substantial functional redundancy between these isoforms, despite their distinct tissue expression patterns (kawamura2015lossofg2 pages 1-2).
While G1 can compensate for G2 loss, the evolutionary conservation of tissue-specific isoforms suggests that they confer subtle functional or regulatory advantages. Yeast studies demonstrate that different a-subunit isoforms (Vph1p vs. Stv1p) direct V-ATPase to different cellular compartments (vacuole vs. Golgi/endosomes) and exhibit differences in coupling efficiency and regulation (vasanthakumar2019structuralcomparisonof pages 1-2, vasanthakumar2019structuralcomparisonof pages 3-4). By analogy, mammalian G isoforms may fine-tune V-ATPase properties for specific neuronal or tissue contexts, even if they are not absolutely required.
A major regulatory mechanism for V-ATPase is the reversible dissociation of V1 and V0 domains (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2). Upon separation, both domains become autoinhibited: isolated V1 loses ATPase activity through conformational changes in subunit H, while V0 becomes impermeant to protons (eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2). The peripheral stalks, including the G subunit, are structurally critical for coordinating this transition and maintaining the inactive states.
The expression of multiple isoforms for several V-ATPase subunits (including B1/B2, C1/C2, E1/E2, G1/G2/G3, a1-4, d1/d2, e1/e2) enables assembly of diverse V-ATPase populations with potentially distinct targeting, activity, or regulatory properties (eaton2021theh+atpase(vatpase) pages 1-5, coutovieira2020multicancervatpasemolecular pages 1-2). Tissue- and organelle-specific isoform combinations may optimize V-ATPase function for specialized cellular contexts.
V-ATPase activity is modulated by interactions with regulatory and accessory proteins involved in trafficking, assembly, and signaling (merkulova2015mappingtheh+ pages 1-2). The V-ATPase interactome includes chaperones (CCT complex subunits), assembly factors (VMA21, TMEM199, CCDC115), trafficking regulators (SNX27, DMXL1, WDR7), and signaling molecules (merkulova2015mappingtheh+ pages 1-2). Knockdown of interacting proteins such as DMXL1 or WDR7 impairs V-ATPase-mediated vesicle acidification, confirming their functional importance (merkulova2015mappingtheh+ pages 1-2).
The V1G subunit class has been identified as a druggable target (wang2020pharmacologicaltargetingof pages 1-3). Verucopeptin, a natural product cyclodepsipeptide, directly binds to ATP6V1G subunits and inhibits both V-ATPase activity and mTORC1 signaling, demonstrating antitumor efficacy against multidrug-resistant cancer cells (wang2020pharmacologicaltargetingof pages 1-3). While this study did not distinguish between G isoforms, it establishes the principle that targeting the G subunit can modulate V-ATPase function therapeutically.
ATP6V1G2 has been identified in prognostic gene signatures for glioma and other cancers (coutovieira2020multicancervatpasemolecular pages 1-2, qi2022identificationofa pages 1-2). A five-gene V-ATPase signature including ATP6V1G2, ATP6V1C2, TCIRG1, ATP6AP1, and ATP6AP2 can sub-classify gliomas into prognostic clusters with distinct malignant phenotypes and immune microenvironments (qi2022identificationofa pages 1-2). High-risk patients show resistance to traditional treatments and altered responses to immune checkpoint blockade (qi2022identificationofa pages 1-2).
Multi-cancer V-ATPase expression profiling revealed differential patterns across tumor types, with imbalances in subunit isoform ratios potentially forming a "conformational code" that influences tumor biology (coutovieira2020multicancervatpasemolecular pages 1-2). However, these associations are primarily correlative, and mechanistic roles for ATP6V1G2 specifically in cancer remain to be fully elucidated.
V-ATPase dysfunction or dysregulation is implicated in multiple cancer hallmarks (chen2022thevatpasesin pages 1-2, chen2024vatpaseincancer pages 1-3):
ATP6V1G2 encodes the brain-enriched G2 isoform of the V-ATPase G subunit, a structural component of the peripheral stalk in the cytosolic V1 domain. The G2 subunit forms heterodimers with the E subunit to create rod-like structures that serve as stators, coupling ATP hydrolysis in the catalytic A3B3 head to proton translocation through the membrane-embedded V0 sector.
G2-containing V-ATPases are predominantly localized to neuronal intracellular compartments including synaptic vesicles, endosomes, and lysosomes, where they establish proton gradients essential for neurotransmitter loading, endolysosomal trafficking, protein degradation, and autophagy. Beyond proton pumping, V-ATPase functions as a signaling platform interfacing with mTORC1, AMPK, and developmental pathways.
Mouse genetic studies demonstrate that G2 is not strictly essential, as the ubiquitous G1 isoform can compensate through post-transcriptional upregulation. Nevertheless, the evolutionary conservation of tissue-specific G isoforms suggests they confer functional advantages for specialized cellular contexts. ATP6V1G2 expression patterns associate with cancer prognosis, particularly in glioma, though mechanistic roles specific to G2 require further investigation.
| Aspect | ATP6V1G2 / V-ATPase subunit G2 summary | Evidence / details | Key sources |
|---|---|---|---|
| Verified identity | Human ATP6V1G2 encodes V-type proton ATPase subunit G2, a member of the V-ATPase G subunit family and the V1 catalytic/peripheral sector of the holoenzyme | Matches the supplied UniProt identity; literature on mammalian V-ATPase recognizes three G-subunit genes/isoforms (G1, G2, G3), with G2 as the neuron/brain-enriched isoform | (abbas2020structureofvatpase pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Protein family / domain context | Small ~13 kDa G subunit of the V1 sector; part of the conserved V-ATPase peripheral stalk architecture | Mammalian V-ATPase V1 contains A3B3CDE3FG3H; G belongs to the triplicated E/G peripheral stalk system that stabilizes the complex during rotary catalysis | (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2) |
| Primary structural role | Structural/statore role rather than direct catalysis: G2 pairs with E subunit to form an elongated peripheral stalk linking catalytic V1 to membrane V0 | Mouse study states G subunit interacts with E to form a rod-like structure connecting catalytic and proton-translocating domains; reviews and structural papers describe three EG heterodimers as peripheral stalks that prevent unproductive rotation of the catalytic head | (vasanthakumar2019structuralcomparisonof pages 1-2, chen2022thevatpasesin pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Position in complex | Located in the cytosolic V1 domain, within the peripheral stalk(s) at the V1–V0 interface | Structural descriptions place E/G with C and H in the stator/peripheral stalk assembly; this connects A3B3 catalytic head to subunit a and the membrane sector | (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2) |
| Catalytic function | No independent enzymatic active site assigned to G2; its function is to support ATP-driven proton pumping by maintaining structural coupling of V1 and V0 | ATP hydrolysis occurs at A/B interfaces; proton transport occurs through V0 c-ring/a interface; G subunits support coupling and assembly rather than directly catalyzing chemistry | (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2) |
| Reaction context of holoenzyme | V-ATPase hydrolyzes ATP to drive H+ translocation across organelle or plasma membranes | Mammalian V-ATPase is an ATP-driven proton pump; ATP hydrolysis in V1 drives rotary motion and proton translocation through V0. Brain V-ATPase structure defined an ATP:H+ ratio of 3:10 | (abbas2020structureofvatpase pages 1-2, wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5) |
| Substrate specificity | Functional substrate context is ATP for energy input and protons (H+) as transported ions | V-ATPases acidify intracellular compartments and, in specialized cells, the extracellular milieu. G2 contributes as a subunit of this pump rather than altering substrate selectivity itself | (wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3) |
| Tissue expression | Brain-/neuron-enriched isoform | Mouse study: G1 is broadly expressed, whereas G2 and G3 show restricted tissue distribution in brain and kidney, respectively; kidney interactome study notes ATP6V1G2 is brain-specific and absent from kidney samples | (merkulova2015mappingtheh+ pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Cell-type specificity | Expressed in neurons, whereas non-neuronal brain cells mainly use G1 | Mouse paper reports neurons express unique G2 in addition to ubiquitous G1, while astrocytes/glia express only G1 | (kawamura2015lossofg2 pages 1-2) |
| Human / mammalian isoform context | Mammals encode three G isoforms with distinct tissue distributions | Reviews and structural work note multiple mammalian isoforms for several V-ATPase subunits, including three G isoforms; isoform diversity likely supports tissue- and compartment-specific V-ATPase populations | (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, coutovieira2020multicancervatpasemolecular pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Subcellular localization inferred for G2-containing complexes | Predominantly in intracellular acidic organelles of neurons, especially synaptic vesicles, endosomes, lysosomes, and secretory vesicles | Brain V-ATPase was purified from synaptic vesicle-rich membranes and mass spectrometry identified G2 as the major G isoform; neuronal V-ATPase energizes synaptic vesicles for neurotransmitter loading | (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, kawamura2015lossofg2 pages 1-2) |
| Direct evidence in brain vesicles | G2 was detected in rat brain V-ATPase preparations from synaptic vesicle-enriched fractions | Mass spectrometry of purified rat-brain V-ATPase identified subunits including G2 and a lower amount of G1, supporting brain vesicle incorporation of G2 | (abbas2020structureofvatpase pages 1-2) |
| Plasma membrane association | Not primarily established for G2 specifically; likely mostly part of intracellular neuronal V-ATPases rather than specialized plasma membrane proton pumps | Reviews emphasize plasma membrane V-ATPases in osteoclasts, kidney intercalated cells, sperm, and some tumors, but G2 is described as brain/neuron-specific rather than these specialized proton-secreting contexts | (eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, duan2018vatpasesandosteoclasts pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Major protein interactions | Forms E–G heterodimer; functionally associated with C, H, and a-subunit-linked stator architecture | Structural and biochemical descriptions indicate EG heterodimers constitute peripheral stalks; G/E alterations affect affinity for C, H, and a and may regulate assembly | (futai2019vacuolartypeatpasea pages 1-3, vasanthakumar2019structuralcomparisonof pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Contribution to assembly | Helps build and stabilize the peripheral stalk/stator, supporting V1–V0 assembly and reversible dissociation behavior | Reviews note peripheral stalks are important for reversible assembly/disassembly; G and E subunits alter affinities with C, H, and a, contributing to assembly regulation | (eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, vasanthakumar2019structuralcomparisonof pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Contribution to rotary mechanism | Serves as part of the stator that resists co-rotation of the catalytic A3B3 head while central stalk/c-ring rotate | This mechanical role is essential for coupling ATP hydrolysis in V1 to H+ transport in V0 without futile rotation of the catalytic head | (wang2020structuresofa pages 1-3, futai2019vacuolartypeatpasea pages 1-3, chen2022thevatpasesin pages 1-2) |
| Biological process: synaptic vesicle acidification | Supports formation of proton gradient in synaptic vesicles needed for neurotransmitter uptake | Neuronal V-ATPase activity generates the proton gradient that powers vesicular neurotransmitter transporters; this is a central, brain-relevant role for G2-containing V-ATPases | (abbas2020structureofvatpase pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Biological process: endocytosis / trafficking | Contributes indirectly to receptor-mediated endocytosis, vesicle trafficking, protein sorting, and membrane trafficking through organelle acidification | V-ATPase acidification is required for endosomes, lysosomes, Golgi function, and vesicle trafficking; interactome and review papers also tie V-ATPase to coat formation and trafficking regulation | (eaton2021theh+atpase(vatpase) pages 1-5, futai2019vacuolartypeatpasea pages 1-3, merkulova2015mappingtheh+ pages 1-2) |
| Biological process: lysosomal degradation / autophagy | Supports lysosomal acidification, enabling degradative enzymes and autophagic flux | Reviews emphasize V-ATPase-dependent lysosomal pH as essential for protein degradation and autophagy; brain dysfunction studies link impaired V-ATPase to neuronal lysosomal defects | (eaton2021theh+atpase(vatpase) pages 1-5, chen2022thevatpasesin pages 1-2, chen2024vatpaseincancer pages 1-3) |
| Biological process: signaling platform | V-ATPase functions not only as a pump but also as a signaling hub, especially for mTORC1 and other pathways | Reviews state V-ATPase directly associates with signaling complexes in Wnt, Notch, and mTOR pathways; cancer review highlights mTORC1 and AMPK coupling to V-ATPase status | (wang2020structuresofa pages 1-3, eaton2021theh+atpase(vatpase) pages 1-5, chen2024vatpaseincancer pages 1-3) |
| Brain-specific functional interpretation | G2 likely tunes V-ATPase function for neuronal secretory and endolysosomal physiology, but is not strictly essential because G1 can compensate in mice | G2-null mice showed no overt architecture/behavior defects; brain tissue upregulated G1 protein without increased G1 mRNA, indicating post-transcriptional or assembly-level compensation | (kawamura2015lossofg2 pages 1-2) |
| Compensation / redundancy | Functional redundancy with G1 is strong in vivo | Loss of G2 caused increased G1 protein accumulation in brain without overt phenotype, implying G1 can replace G2 in many complexes despite neuron-biased G2 expression | (kawamura2015lossofg2 pages 1-2) |
| Disease / pathology evidence specific to ATP6V1G2 | Direct mechanistic disease literature is limited; current evidence is mainly expression-association rather than causation | ATP6V1G2 appears in glioma prognostic signatures and cancer expression studies, but these do not yet establish a specific biochemical disease mechanism for G2 itself | (coutovieira2020multicancervatpasemolecular pages 1-2, qi2022identificationofa pages 1-2) |
| Cancer-associated observations | ATP6V1G2 expression has been incorporated into glioma classification/prognostic signatures; broader V-ATPase dysregulation is implicated in cancer invasion, metabolism, and drug resistance | V-ATPase-wide studies identify ATP6V1G2 among prognostic genes in glioma; broader reviews link V-ATPase activity to acidic tumor microenvironment and mTORC1-related cancer biology | (chen2024vatpaseincancer pages 1-3, coutovieira2020multicancervatpasemolecular pages 1-2, qi2022identificationofa pages 1-2, wang2020pharmacologicaltargetingof pages 1-3) |
| Regulatory mechanisms: reversible assembly | V-ATPase activity is regulated by reversible dissociation/assembly of V1 and V0, a process in which peripheral stalks containing G are structurally important | Reviews and structural studies describe regulated V1–V0 separation with autoinhibition of each sector; stalk architecture is central to this transition | (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2, kawamura2015lossofg2 pages 1-2) |
| Regulatory mechanisms: isoform composition | Isoform composition is a major regulatory principle for targeting and possibly coupling efficiency | Mammalian V-ATPases contain multiple isoforms of several subunits; tissue-dependent isoform combinations likely produce distinct complexes. Yeast isoform work supports isoform-dependent localization and activity differences, suggesting analogous principles in mammals | (eaton2021theh+atpase(vatpase) pages 1-5, vasanthakumar2019structuralcomparisonof pages 1-2, coutovieira2020multicancervatpasemolecular pages 1-2) |
| Regulatory mechanisms: accessory / interacting proteins | V-ATPase function is modulated by assembly factors and interactors involved in folding, trafficking, and signaling | Kidney interactome identified multiple novel associated proteins and highlighted regulation through quality control, trafficking, and phosphorylation machinery; while G2 was not present in kidney, these mechanisms likely generalize to V-ATPase biology | (merkulova2015mappingtheh+ pages 1-2) |
| Regulatory mechanisms: pharmacologic targeting | The V1G subunit class is druggable in principle | Verucopeptin directly targeted ATP6V1G subunit(s) and inhibited V-ATPase activity and mTORC1 signaling in multidrug-resistant cancer models; this study focused on V1G generally, not specifically G2 | (wang2020pharmacologicaltargetingof pages 1-3) |
| Current evidence strength for ATP6V1G2-specific function | Moderate for expression/localization; indirect for molecular specialization | Strong evidence supports G2 as a neuronal V-ATPase G isoform incorporated into brain vesicle V-ATPase complexes; however, most mechanistic conclusions come from general V-ATPase/subunit G studies or mouse compensation data rather than human G2-specific perturbation studies | (abbas2020structureofvatpase pages 1-2, eaton2021theh+atpase(vatpase) pages 1-5, kawamura2015lossofg2 pages 1-2) |
Table: This table compiles the main structural, functional, localization, interaction, and regulatory features of human ATP6V1G2/V-ATPase subunit G2 from the reviewed literature. It is useful as a compact evidence map distinguishing what is directly known about G2 from what is inferred from broader V-ATPase biology.
The evidence base for ATP6V1G2 is moderate for expression patterns and general V-ATPase mechanisms, but direct functional studies specifically dissecting G2 versus G1 roles in human neurons or disease contexts remain limited. Future research defining isoform-specific regulatory mechanisms, interacting partners, and therapeutic targeting strategies will enhance our understanding of this neuron-enriched V-ATPase component.
References
(abbas2020structureofvatpase pages 1-2): Yazan M. Abbas, Di Wu, Stephanie A. Bueler, Carol V. Robinson, and John L. Rubinstein. Structure of v-atpase from the mammalian brain. Mar 2020. URL: https://doi.org/10.1126/science.aaz2924, doi:10.1126/science.aaz2924. This article has 278 citations and is from a highest quality peer-reviewed journal.
(eaton2021theh+atpase(vatpase) pages 1-5): Amity F. Eaton, Maria Merkulova, and Dennis Brown. The h+-atpase (v-atpase): from proton pump to signaling complex in health and disease. Mar 2021. URL: https://doi.org/10.1152/ajpcell.00442.2020, doi:10.1152/ajpcell.00442.2020. This article has 189 citations.
(kawamura2015lossofg2 pages 1-2): Nobuyuki Kawamura, Ge-Hong Sun-Wada, and Yoh Wada. Loss of g2 subunit of vacuolar-type proton transporting atpase leads to g1 subunit upregulation in the brain. Scientific Reports, Sep 2015. URL: https://doi.org/10.1038/srep14027, doi:10.1038/srep14027. This article has 14 citations and is from a peer-reviewed journal.
(wang2020structuresofa pages 1-3): Longfei Wang, Di Wu, Carol V. Robinson, Hao Wu, and Tian-Min Fu. Structures of a complete human v-atpase reveal mechanisms of its assembly. Molecular Cell, 80:501-511.e3, Nov 2020. URL: https://doi.org/10.1016/j.molcel.2020.09.029, doi:10.1016/j.molcel.2020.09.029. This article has 182 citations and is from a highest quality peer-reviewed journal.
(futai2019vacuolartypeatpasea pages 1-3): Masamitsu FUTAI, Ge-Hong SUN-WADA, Yoh WADA, Naomi MATSUMOTO, and Mayumi NAKANISHI-MATSUI. Vacuolar-type atpase: a proton pump to lysosomal trafficking. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 95:261-277, Jun 2019. URL: https://doi.org/10.2183/pjab.95.018, doi:10.2183/pjab.95.018. This article has 145 citations.
(chen2022thevatpasesin pages 1-2): Fangquan Chen, Rui Kang, Jiao Liu, and Daolin Tang. The v-atpases in cancer and cell death. Cancer Gene Therapy, 29:1529-1541, May 2022. URL: https://doi.org/10.1038/s41417-022-00477-y, doi:10.1038/s41417-022-00477-y. This article has 128 citations and is from a peer-reviewed journal.
(vasanthakumar2019structuralcomparisonof pages 1-2): Thamiya Vasanthakumar, Stephanie A. Bueler, Di Wu, Victoria Beilsten-Edmands, Carol V. Robinson, and John L. Rubinstein. Structural comparison of the vacuolar and golgi v-atpases from saccharomyces cerevisiae. Proceedings of the National Academy of Sciences, 116:7272-7277, Mar 2019. URL: https://doi.org/10.1073/pnas.1814818116, doi:10.1073/pnas.1814818116. This article has 97 citations and is from a highest quality peer-reviewed journal.
(vasanthakumar2019structuralcomparisonof pages 3-4): Thamiya Vasanthakumar, Stephanie A. Bueler, Di Wu, Victoria Beilsten-Edmands, Carol V. Robinson, and John L. Rubinstein. Structural comparison of the vacuolar and golgi v-atpases from saccharomyces cerevisiae. Proceedings of the National Academy of Sciences, 116:7272-7277, Mar 2019. URL: https://doi.org/10.1073/pnas.1814818116, doi:10.1073/pnas.1814818116. This article has 97 citations and is from a highest quality peer-reviewed journal.
(merkulova2015mappingtheh+ pages 1-2): Maria Merkulova, Teodor G. Păunescu, Anie Azroyan, Vladimir Marshansky, Sylvie Breton, and Dennis Brown. Mapping the h+ (v)-atpase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation. Scientific Reports, Oct 2015. URL: https://doi.org/10.1038/srep14827, doi:10.1038/srep14827. This article has 164 citations and is from a peer-reviewed journal.
(chen2024vatpaseincancer pages 1-3): Tingting Chen, Xiaotan Lin, Shuo Lu, and Bo Li. V-atpase in cancer: mechanistic insights and therapeutic potentials. Cell Communication and Signaling : CCS, Dec 2024. URL: https://doi.org/10.1186/s12964-024-01998-9, doi:10.1186/s12964-024-01998-9. This article has 25 citations.
(coutovieira2020multicancervatpasemolecular pages 1-2): Juliana Couto-Vieira, Pedro Nicolau-Neto, Evenilton Pessoa Costa, Frederico Firme Figueira, Tatiana de Almeida Simão, Anna Lvovna Okorokova-Façanha, Luis Felipe Ribeiro Pinto, and Arnoldo Rocha Façanha. Multi-cancer v-atpase molecular signatures: a distinctive balance of subunit c isoforms in esophageal carcinoma. EBioMedicine, 51:102581, Jan 2020. URL: https://doi.org/10.1016/j.ebiom.2019.11.042, doi:10.1016/j.ebiom.2019.11.042. This article has 34 citations and is from a peer-reviewed journal.
(wang2020pharmacologicaltargetingof pages 1-3): Yuezhou Wang, Lei Zhang, Yanling Wei, Wei Huang, Li Li, An-An Wu, A. Dastur, Patricia Greninger, Walter Bray, Chen-song Zhang, Mengqi Li, Wenhua Lian, Zhiyu Hu, Xiaoyong Wang, G. Liu, L. Yao, J. Guh, Lanfen Chen, Hong-Rui Wang, Dawang Zhou, Sheng-Cai Lin, Qingyan Xu, Yuemao Shen, Jianming Zhang, M. Jurica, C. Benes, and Xianming Deng. Pharmacological targeting of vacuolar h+-atpase via subunit v1g combats multidrug-resistant cancer. Cell chemical biology, Jun 2020. URL: https://doi.org/10.1016/j.chembiol.2020.06.011, doi:10.1016/j.chembiol.2020.06.011. This article has 30 citations and is from a domain leading peer-reviewed journal.
(qi2022identificationofa pages 1-2): Chunxiao Qi, Lei Lei, Jinqu Hu, Gang Wang, Jiyuan Liu, and Shaowu Ou. Identification of a five-gene signature deriving from the vacuolar atpase (v-atpase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations. Cell Cycle, 21:1294-1315, Mar 2022. URL: https://doi.org/10.1080/15384101.2022.2049157, doi:10.1080/15384101.2022.2049157. This article has 19 citations and is from a peer-reviewed journal.
(duan2018vatpasesandosteoclasts pages 1-2): Xiaohong Duan, Shaoqing Yang, Lei Zhang, and Tielin Yang. V-atpases and osteoclasts: ambiguous future of v-atpases inhibitors in osteoporosis. Theranostics, 8:5379-5399, Oct 2018. URL: https://doi.org/10.7150/thno.28391, doi:10.7150/thno.28391. This article has 86 citations and is from a domain leading peer-reviewed journal.